ABCL EPS Estimates
AbCellera Biologics Inc.
$12.02
-$0.81(-6.31%)
66
Overall
--
Value
91
Tech
42
Quality
Market Cap
$4.16B
Volume
8.47M
52W Range
$2.75 - $15.02
Target Price
$16.70
ABCL EPS estimates: the consensus estimate for AbCellera Biologics Inc.'s current fiscal year is -$0.69 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ABCL EPS Estimates
- EPS estimate, current quarter
- $-0.18
- EPS estimate, next quarter
- $-0.19
- EPS estimate, current year
- $-0.69
- EPS estimate, next year
- $-0.82
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.49 |
| 2023 | $-0.51 |
| 2022 | $0.56 |
| 2021 | $0.56 |
| 2020 | $0.53 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABCL | $12.02 | -6.3% | 8.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get AbCellera Biologics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW